Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 3
1989 1
1990 3
1992 4
1993 4
1994 3
1996 2
1997 7
1998 7
1999 5
2000 1
2001 8
2002 4
2003 11
2004 8
2005 6
2006 3
2007 6
2008 11
2009 6
2010 8
2011 7
2012 9
2013 4
2014 6
2015 8
2016 10
2017 9
2018 8
2019 12
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
Is Collaborative Ocular Melanoma Study (COMS) still relevant?
Honavar SG. Honavar SG. Indian J Ophthalmol. 2018 Oct;66(10):1385-1387. doi: 10.4103/ijo.IJO_1588_18. Indian J Ophthalmol. 2018. PMID: 30249817 Free PMC article. No abstract available.
The collaborative ocular melanoma study.
Singh AD, Kivelä T. Singh AD, et al. Ophthalmol Clin North Am. 2005 Mar;18(1):129-42, ix. doi: 10.1016/j.ohc.2004.11.004. Ophthalmol Clin North Am. 2005. PMID: 15763198 Review.
This review provides a summary of the main objectives, significant design features, and major findings and achievements of the Collaborative Ocular Melanoma Study (COMS). ...Because the randomized design of the COMS was unique, no attempt is made to ma …
This review provides a summary of the main objectives, significant design features, and major findings and achievements of the Collaborat
The Collaborative Ocular Melanoma Study: an overview.
Margo CE. Margo CE. Cancer Control. 2004 Sep-Oct;11(5):304-9. doi: 10.1177/107327480401100504. Cancer Control. 2004. PMID: 15377989 Review.
BACKGROUND: The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter randomized clinical trials designed to compare the effectiveness of brachytherapy to enucleation for treatment of medium-size choroidal …
BACKGROUND: The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter …
Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
Hawkins BS. Hawkins BS. Clin Trials. 2011 Oct;8(5):661-73. doi: 10.1177/1740774511419684. Clin Trials. 2011. PMID: 22013172 Clinical Trial.
PURPOSE: The Collaborative Ocular Melanoma Study (COMS) was designed to compare enucleation and radiotherapy among similar patients with respect to survival outcomes. ...CONCLUSIONS: The multidisciplinary COMS Group not only successfully conducted a ra …
PURPOSE: The Collaborative Ocular Melanoma Study (COMS) was designed to compare enucleation and radiotherapy amo …
Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK, Studenski MT, Paez-Escamilla MA, Walter SD, Kwon D, Markoe AM, Harbour JW, Samuels SE. Dean MK, et al. Brachytherapy. 2019 May-Jun;18(3):404-410. doi: 10.1016/j.brachy.2019.01.005. Epub 2019 Feb 20. Brachytherapy. 2019. PMID: 30797699
PURPOSE: We sought to formally compare Collaborative Ocular Melanoma Study (COMS) and similar-shaped (circular) eye physics (EP) plaques dosimetrically by examining both tumor coverage and critical structure doses. ...CONCLUSIONS: Overall, neither the …
PURPOSE: We sought to formally compare Collaborative Ocular Melanoma Study (COMS) and similar-shaped (circular) …
An improved treatment planning and quality assurance process for Collaborative Ocular Melanoma Study eye plaque brachytherapy.
Weersink RA, Patterson S, Ballantyne H, Di Tomasso A, Borg J, Vitkin A, Rink A, Beiki-Ardakani A. Weersink RA, et al. Brachytherapy. 2019 Sep-Oct;18(5):658-667. doi: 10.1016/j.brachy.2019.05.008. Epub 2019 Jun 22. Brachytherapy. 2019. PMID: 31235445
PURPOSE: To develop a treatment planning platform for episcleral Collaborative Ocular Melanoma Study plaque therapy in an established treatment planning software and to improve an existing quality assurance (QA) process for nonuniformly loaded plaques …
PURPOSE: To develop a treatment planning platform for episcleral Collaborative Ocular Melanoma Study plaque ther …
Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
Johnson JE, Deufel CL, Furutani KM. Johnson JE, et al. Brachytherapy. 2016 Sep-Oct;15(5):661-8. doi: 10.1016/j.brachy.2016.06.002. Epub 2016 Jul 27. Brachytherapy. 2016. PMID: 27475484
PURPOSE: To quantify the dosimetric effects of random and systematic seed position uncertainties in Collaborative Ocular Melanoma Study-based eye plaques. ...Dose was calculated at four ocular anatomic sites and three central axis plaque depths. …
PURPOSE: To quantify the dosimetric effects of random and systematic seed position uncertainties in Collaborative Ocular Me
The Collaborative Ocular Melanoma Study, mortality by therapeutic approach, age and tumor size.
Lund RW. Lund RW. J Insur Med. 2013;43(4):221-6. J Insur Med. 2013. PMID: 24069782
OBJECTIVES: Determine the mortality ratios and excess deaths associated with the two therapeutic options for both the small and the large tumor groups and for subsets of age and tumor size within each group as presented in the Collaborative Ocular Melanoma
OBJECTIVES: Determine the mortality ratios and excess deaths associated with the two therapeutic options for both the small and the large tu …
Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry JL. Le BHA, et al. Brachytherapy. 2018 Nov-Dec;17(6):981-989. doi: 10.1016/j.brachy.2018.07.002. Epub 2018 Aug 3. Brachytherapy. 2018. PMID: 30082188 Free PMC article.
We hypothesize that the PS/EP system delivers lower doses to critical ocular structures, resulting in lower rates of radiation toxicity and favorable visual outcomes compared to Collaborative Ocular Melanoma Study plaques, while maintaining adeq …
We hypothesize that the PS/EP system delivers lower doses to critical ocular structures, resulting in lower rates of radiation toxici …
182 results
Jump to page
Feedback